Supernus Pharmaceuticals reported $60.15M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Aerie Pharmaceuticals AERI:US $ 30.06M 0.65M
Ani Pharmaceuticals ANIP:US $ 61.68M 5.95M
Antares Pharma ATRS:US $ 16.49M 2.15M
Aphria Inc APH:CN C$ 340.86M 9.58M
Aurora Cannabis Inc ACB:CN 155.82M 18.1M
Bristol Myers Squibb BMY:US $ 2163M 26M
Canopy Growth Corp WEED:CN C$ 86.9M 324.77M
Corcept Therapeutics CORT:US $ 4.99M 0.32M
Eisai 4523:JP Y 90043M 191M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Endo International Ordinary Shares ENDP:US $ 297.3M 41.15M
Horizon Pharma HZNP:US $ 237.43M 21.24M
JAZZ PHA JAZZ:US $ 1137.85M 113.41M
Lannett LCI:US $ 112.64M 3.09M
Pacira Pharmaceuticals PCRX:US $ 67.21M 1.94M
Perrigo Ordinary Shares PRGO:US $ 1092.5M 23.4M
Revance Therapeutics RVNC:US $ 10.19M 5.13M
Supernus Pharmaceuticals SUPN:US $ 60.16M 1.76M
Teva Pharmaceutical Industries TEVA:US $ 4167M 195M
United Therapeutics UTHR:US $ 96.7M 6.8M
Xeris Pharmaceuticals Inc XERS:US $ 14.24M 1.94M